122 related articles for article (PubMed ID: 37902585)
41. A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML.
Lieske A; Agyeman-Duah E; Selich A; Dörpmund N; Talbot SR; Schambach A; Maetzig T
Leukemia; 2023 Jan; 37(1):79-90. PubMed ID: 36517672
[TBL] [Abstract][Full Text] [Related]
42. Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of
Walker AR; Byrd JC; Blachly JS; Bhatnagar B; Mims AS; Orwick S; Lin TL; Crosswell HE; Zhang D; Minden MD; Munugalavadla V; Long L; Liu J; Pan Y; Oellerich T; Serve H; Rao AV; Blum WG
Clin Cancer Res; 2020 Nov; 26(22):5852-5859. PubMed ID: 32820015
[TBL] [Abstract][Full Text] [Related]
43. Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?
Somervaille TC; Cleary ML
Int J Hematol; 2010 Jun; 91(5):735-41. PubMed ID: 20454944
[TBL] [Abstract][Full Text] [Related]
44. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
[No Abstract] [Full Text] [Related]
45. Meis2 as a critical player in MN1-induced leukemia.
Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
[TBL] [Abstract][Full Text] [Related]
46. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
47. [The Involvement of Cardiomyocyte-Specific Transcription Factors Meis in Adipocyte Differentiation].
Greco A; Vaipan DV; Tkachuk VA; Penkov DN
Mol Biol (Mosk); 2019; 53(3):497-501. PubMed ID: 31184615
[TBL] [Abstract][Full Text] [Related]
48. A role for MEIS1 in MLL-fusion gene leukemia.
Kumar AR; Li Q; Hudson WA; Chen W; Sam T; Yao Q; Lund EA; Wu B; Kowal BJ; Kersey JH
Blood; 2009 Feb; 113(8):1756-8. PubMed ID: 19109563
[TBL] [Abstract][Full Text] [Related]
49. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.
Jin G; Yamazaki Y; Takuwa M; Takahara T; Kaneko K; Kuwata T; Miyata S; Nakamura T
Blood; 2007 May; 109(9):3998-4005. PubMed ID: 17227832
[TBL] [Abstract][Full Text] [Related]
50. Gfi1 integrates progenitor versus granulocytic transcriptional programming.
Horman SR; Velu CS; Chaubey A; Bourdeau T; Zhu J; Paul WE; Gebelein B; Grimes HL
Blood; 2009 May; 113(22):5466-75. PubMed ID: 19346496
[TBL] [Abstract][Full Text] [Related]
51. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.
Zhi L; Wang M; Rao Q; Yu F; Mi Y; Wang J
Cancer Lett; 2010 Oct; 296(1):65-73. PubMed ID: 20444543
[TBL] [Abstract][Full Text] [Related]
52. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
53. Homeodomain transcription factor Meis1 is a critical regulator of adult bone marrow hematopoiesis.
Ariki R; Morikawa S; Mabuchi Y; Suzuki S; Nakatake M; Yoshioka K; Hidano S; Nakauchi H; Matsuzaki Y; Nakamura T; Goitsuka R
PLoS One; 2014; 9(2):e87646. PubMed ID: 24498346
[TBL] [Abstract][Full Text] [Related]
54. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract][Full Text] [Related]
55. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.
Chang CP; Jacobs Y; Nakamura T; Jenkins NA; Copeland NG; Cleary ML
Mol Cell Biol; 1997 Oct; 17(10):5679-87. PubMed ID: 9315626
[TBL] [Abstract][Full Text] [Related]
56. Identification of E74-like factor 1 (ELF1) as a transcriptional regulator of the Hox cofactor MEIS1.
Xiang P; Lo C; Argiropoulos B; Lai CB; Rouhi A; Imren S; Jiang X; Mager D; Humphries RK
Exp Hematol; 2010 Sep; 38(9):798-8, 808.e1-2. PubMed ID: 20600580
[TBL] [Abstract][Full Text] [Related]
57. Elucidating the importance and regulation of key enhancers for human MEIS1 expression.
Xiang P; Yang X; Escano L; Dhillon I; Schneider E; Clemans-Gibbon J; Wei W; Wong J; Wang SX; Tam D; Deng Y; Yung E; Morin GB; Hoodless PA; Hirst M; Karsan A; Kuchenbauer F; Humphries RK; Rouhi A
Leukemia; 2022 Aug; 36(8):1980-1989. PubMed ID: 35624144
[TBL] [Abstract][Full Text] [Related]
58. MEIS1 regulates early erythroid and megakaryocytic cell fate.
Zeddies S; Jansen SB; di Summa F; Geerts D; Zwaginga JJ; van der Schoot CE; von Lindern M; Thijssen-Timmer DC
Haematologica; 2014 Oct; 99(10):1555-64. PubMed ID: 25107888
[TBL] [Abstract][Full Text] [Related]
59. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression.
Chen JL; Li J; Kiriluk KJ; Rosen AM; Paner GP; Antic T; Lussier YA; Vander Griend DJ
Clin Cancer Res; 2012 Aug; 18(16):4291-302. PubMed ID: 22723371
[TBL] [Abstract][Full Text] [Related]
60. A conserved motif N-terminal to the DNA-binding domains of myogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1.
Knoepfler PS; Bergstrom DA; Uetsuki T; Dac-Korytko I; Sun YH; Wright WE; Tapscott SJ; Kamps MP
Nucleic Acids Res; 1999 Sep; 27(18):3752-61. PubMed ID: 10471746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
